Submissions from 2024
Identification of New Biomarkers in Diabetic Distal Symmetrical Polyneuropathy With Conduction Slowing: A Prospective Proteomics Analysis (P8-11.003), Kazim Jaffry, Kelly Saverino, Joseph Wardell, Belinda Philip, Ankit Pahwa, Daniel Menkes, Zhao Zhong Chong, and Nizar Souayah
Associations Between Interleukin-6 (IL-6) and the Outcomes of Post-Acute Sequelae of COVID-19 (PASC): An EPIC Electronic Medical Record System Retrospective Study (P11-13.003), James Lin, Kazim Jaffry, Suyayb Islam, Scott Karpenos, Narjis Jaffry, Justin Matos, Daniel Menkes, and Nizar Souayah
Clinical and Biological Markers of Conduction Slowing in Diabetic Distal Symmetrical Polyneuropathy: A Prospective Study (P8-11.012), Kelly Saverino, Joseph Wardell, Kazim Jaffry, Mustafa Jaffry, Suhayb Islam, Daniel Menkes, and NIzar Souayah
Rhabdomyolysis in Acute COVID-19 Infection: A Descriptive Outcomes Analysis (P9-13.010), Roopa Sharma, Kazim Jaffry, Justin Matos, Scott Karpenos, James Lin, Narjis Jaffry, Suhayb Islam, Kranthi Mandava, Daniel Menkes, and Nazir Souayah
Natural History of Acquired Demyelination in Diabetic Distal Symmetric Polyneuropathy (P9-11.014), Roopa Sharma, Daniel Menkes, Kazim Jaffry, Iqra Faiz, and Nizar Souayah
Lipidomic Biomarkers in Diabetic Distal Symmetrical Polyneuropathy With Conduction Slowing (P8-11.015), Joseph Wardell, Zhao Zhong Chong, Kelly Saverino, Kazim Jaffry, Belinda Philip, Tejas Patel, Abu Nasar, Ankit Pahwa, Daniel Menkes, and Nizar Souayah
Is There an Association Between Serum Neurofilament Light Chain Levels and Conduction Slowing in Type 2 Diabetic Distal Symmetrial Polyneuropathy? (P3-4.003), Joseph Wardell, Kelly Saverino, Belinda Philip, Kazim Jaffry, Ankit Pahwa, Daniel Menkes, Zhao Zhong Chong, and Nizar Souayah
Submissions from 2023
Expert Agreement on Identification and Characterization of Electrographic Seizures, James Castellano, Rishabh Jain, Wesley Kerr, Laura Szklarski, Arun Antony, Thander Aung, Maria Baldwin, Niravkumar Barot, Joanna Fong-Isariyawongse, and Andrew Zillgitt
Submissions from 2022
9-month course of refractory anti-NMDA receptor encephalitis with initial negative markers: diagnostic and therapeutic challenges, Camilla Cascardo, Alexander Ismail, Francisco Davila, and Nicole Marijanovich
Neurologic complications of cancer, David Green
Status epilepticus, David Green
Stroke Teams: Can an Emergency Room Team provide quicker door-to-needle times than a Neurology Team?, Scott Klein, Amy Wallace, Dawn Zelenka, and Joshua Nass
Responsive Neurostimulation (RNS) of the Centromedian Nucleus of the Thalamus for the Treatment of Drug Resistant Idiopathic Generalized Epilepsy, Angelique Manasseh, Hannah Guider, Brooklynn Bondy, Ayman Haykal, Nour Baki, Ashleigh Terrell, Michael Staudt, Christopher Parres, and Andrew Zillgitt
Submissions from 2021
Evoked potentials in the diagnosis of peripheral and central nervous system disorders. Pediatric Epilepsy: New and Novel Approaches, Daniel L. Menkes
The Guillain Barre Syndrome, Daniel L. Menkes
Update on the Guillain-Barre Syndrome, Daniel L. Menkes
Neurologic prognostication after cardiac arrest, Christopher Parres
Adult Clinical MEG Cases, Andrew Zillgitt
Clinical Utility of Magnetoencephalography (MEG): Standard clinical practice and coherence source imaging, Andrew Zillgitt
Managing critical care seizures and drug resistant epilepsy, Andrew Zillgitt
Temporal Lobe Epilepsy: Surgical treatment options for the most common, but heterogenous, and at times hidden, focal epilepsy, Andrew Zillgitt
The Most Common Focal Epilepsies: Differentiating temporal lobe epilepsy and frontal lobe epilepsy, Andrew Zillgitt
The utility of MEG in the epilepsy presurgical evaluation Pediatric Epilepsy: New and Novel Approaches, Andrew Zillgitt
Submissions from 2018
CSF lamp2 concentrations are decreased in female Parkinson's disease patients with LRRK2 mutations., Andrea C. Klaver, Mary P Coffey, and David A. Loeffler